AMGN

Amgen Inc.

HealthcareDrug Manufacturers - GeneralUSUSD

$336.79

-0.77%Live · FMPMay 29, 2026

Market cap

$181.77B

52w range

267.83 – 391.29

P / E

—

EPS

—

Volume

2.95M

Revenue · FY

$36.74B

+9.92% YoY

Stock splits

DB · stock_splits5

Date	Ratio	Type	Multiplier
Nov 22, 1999	2-for-1	Forward	2.00×
Mar 01, 1999	2-for-1	Forward	2.00×
Aug 16, 1995	2-for-1	Forward	2.00×
Sep 11, 1991	3-for-1	Forward	3.00×
Aug 13, 1990	2-for-1	Forward	2.00×

3DB · FMP /mergers-acquisitions

Whole-company transactions where AMGN is acquirer or target.

Date	Role	Counterparty	Filing
Apr 23, 2004	Acquirer	Tularik	SEC →
Jan 31, 2002	Acquirer	Immunex	SEC →
Nov 03, 2000	Acquirer	Kinetix	SEC →

DB · 13D/G9

Filed	Form	Reporter	% owned	Shares
Sep 27, 2023	—	Amgen Inc.	23.20%	—	SEC →
Dec 02, 2022	—	SAGA INVESTMENTS COÖPERATIEF U.A.	6.00%	—	SEC →
Dec 02, 2022	—	AMGEN SINGAPORE MANUFACTURING PTE. LTD.	6.00%	—	SEC →
Dec 02, 2022	—	ONYX PHARMACEUTICALS, INC.	6.00%	—	SEC →
Dec 02, 2022	—	AMGEN INC.	6.00%	—	SEC →
Dec 02, 2022	—	AMGEN TECHNOLOGY, LIMITED	6.00%	—	SEC →
Feb 10, 2022	—	STATE STREET CORPORATION	5.37%	—	SEC →
Jan 12, 2022	—	AMGEN INC.	11.30%	—	SEC →
Oct 01, 2021	—	AMGEN INC.	7.40%	—	SEC →

Corporate actions combine splits (live, full history), symbol changes (refreshed weekly), the daily M&A wire, and 13D/G filings.